Breakthrough T1D Report: How HbA1c Came to Be
Accurate control of blood sugar for people with type 1 diabetes (T1D) was not easy in the 1970s. At the…
FDA Approves an Artificial Pancreas System for Children Aged 2-6 Years
The Food and Drug Administration (FDA) approved the Medtronic MiniMed 770G artificial pancreas system for use by children aged 2…
Tandem Control-IQ Improves T1D Management in Children Ages 6 and Up
A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system—which…
Microbiome Reset: Clinical Trial in Newly Diagnosed Youth
While genetics play a major role in the development of type 1 diabetes (T1D), mounting evidence supports the strong influence…
Solving Big Challenges in Beta Cell Transplantation
You’re going to hear about a part of your body that, really, goes unnoticed in type 1 diabetes (T1D): blood…
Breakthrough T1D Researchers Develop a Combined Risk Score to Predict Which Children Develop T1D
Type 1 diabetes (T1D) can be hard to predict in high risk children. Testing for the presence of T1D autoantibodies—antibodies…
Cell Therapy Approaches Moving Along the Pipeline
Beta cell replacement therapies for type 1 diabetes (T1D) have made significant advances in just the past 10 years. We…
Accelerating Our Mission and Becoming More Volunteer Powered
Our bold vision for the future outlines strategies to drive greater impact to unlock cures and drive research that improves…
Myth vs. Fact: COVID-19 Can Trigger Diabetes
It’s been around the news: COVID-19 might trigger diabetes, at least in some people. That’s what several Breakthrough T1D-funded scientists…
Tandem Diabetes Care in the Real World
Two leaders from Tandem Diabetes Care share real-world outcomes from Tandem insulin pump users, other practical insights.
